EW Stock Recent News

EW LATEST HEADLINES

EW Stock News Image - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:30 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day. A.

Business Wire 2024 Feb 23
EW Stock News Image - Zacks Investment Research

Edwards (EW) is demonstrating the strong performance of the SAPIEN 3 Ultra valve in the United States, Europe and Rest of World.

Zacks Investment Research 2024 Feb 15
EW Stock News Image - Zacks Investment Research

Edwards Lifesciences' (EW) Q4 revenues register year-over-year growth on its strong differentiated portfolio of advanced therapies.

Zacks Investment Research 2024 Feb 07
EW Stock News Image - Seeking Alpha

Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript

Seeking Alpha 2024 Feb 06
EW Stock News Image - Zacks Investment Research

Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research 2024 Feb 06
EW Stock News Image - Zacks Investment Research

Edwards Lifesciences (EW) came out with quarterly earnings of $0.64 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.64 per share a year ago.

Zacks Investment Research 2024 Feb 06
EW Stock News Image - Reuters

Edwards Lifesciences reported fourth-quarter profit on Tuesday that beat Wall Street estimates, helped by strong demand for the company's artificial heart valves and other devices.

Reuters 2024 Feb 06
EW Stock News Image - Zacks Investment Research

Edwards Lifesciences' (EW) EVOQUE valve replacement system becomes the first transcatheter therapy to earn FDA approval for a tricuspid valve.

Zacks Investment Research 2024 Feb 06
EW Stock News Image - Zacks Investment Research

Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research 2024 Feb 05
EW Stock News Image - Zacks Investment Research

Beyond analysts' top -and-bottom-line estimates for Edwards Lifesciences (EW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Zacks Investment Research 2024 Feb 01
10 of 50